Home › Lung Cancer › North Carolina › Greensboro
Lung Cancer clinical trials in Greensboro, NC
3 studies for Lung Cancer are looking for participants at sites in and around Greensboro (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Cone Health Cancer Center, Greensboro
- Cone Health Cancer Center at Drawbridge Parkway, Greensboro
- Cone Health Cancer Center at Alamance Regional, Burlington · 20 mi away
- and 1 more
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- Novant Health Breast Surgery - Greensboro, Greensboro
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
RecruitingObservational study
- PulmonIx, LLC, Greensboro
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Arlington, VA41 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Baltimore, MD40 studies
- Nashville, TN40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Greensboro
- Overweight12 studies
- Obesity12 studies
- Type 2 Diabetes6 studies
- Heart Failure6 studies
- Breast Cancer5 studies
- Cardiovascular Disease5 studies
- HIV4 studies
- Stroke4 studies
- Interstitial Lung Diseases4 studies
- Heart Attack4 studies
- Idiopathic Pulmonary Fibrosis3 studies
- Atherosclerosis3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.